In this issue of Immunology & Allergy Clinics, guest editor Dr. Marcus S. Shaker brings his considerable expertise to the topic of Anaphylaxis. Top experts provide updates on anaphylaxis epidemiology, guidelines, and diagnostics, as well as mast cell activation syndrome, mastocytosis, novel therapies, and more.- Contains 15 relevant, practice-oriented topics including venom anaphylaxis; anaphylaxis guidelines; equity and anaphylaxis; future anaphylaxis therapies; novel epinephrine delivery devices; preventing food anaphylaxis; and more- Provides in-depth clinical reviews on anaphylaxis, offering actionable insights for clinical practice- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
Anaphylaxis Epidemiology and Risk FactorsAnaphylaxis: Clinical Criteria, Severity, and Clinical Courses
Community Anaphylaxis
Equity and Anaphylaxis
Anaphylaxis Guidelines
Preventing Food Anaphylaxis
Drug Anaphylaxis
Beta-Blockers, Angiotensin-Converting Enzyme Inhibitors, and Anaphylaxis
Iodinated Contrast Media and Anaphylaxis
Venom Anaphylaxis
Novel Epinephrine Delivery Devices
Emerging Therapies for Anaphylaxis
Hereditary Alpha-Tryptasemia (H?T) as a Risk Modifier for Severe Anaphylaxis
Mast Cell Activation Syndrome and Mimickers
